Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Tamoxifen × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Carcinoma, Intraductal, Noninfiltrating 6 Breast Carcinoma In Situ 4 Neoplasms 3 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 ERα+ Breast Cancer 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

exemestane 1 abemaciclib 1 Tamoxifen 1 Mastectomy 1 Letrozole 1 Dexmedetomidine 1 Bupivacaine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡